Figure 7From: Individualized markers optimize class prediction of microarray dataSeparation of ER- and ER+ breast cancer samples. According to the immunoblotting classification, our method has two misclassified samples, namely 14 and 31. However, both samples are placed at the furthest end of the ER+ cluster and are joined in a single branch, possibly indicating an intermediate disease stage.Back to article page